4D Molecular Therapeutics, Inc. (FDMT) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts FDMT Hot Sheet
Join SI Premium – FREE
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) reported Q2 EPS of ($0.63), $0.05 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $10 thousand versus the consensus estimate of $1.27 million.
For earnings history and earnings-related data on 4D Molecular Therapeutics, Inc. (FDMT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump Says He's Close To Decision On Massive Iran Attack - Axios
- Kearny Financial (KRNY) Misses Q4 EPS by 2c
- Infosys Limited (INFY) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
